Skip to content

The development of shoulder pain after stroke.

The relation between somatosensation, nociception and the development of shoulder pain after stroke.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22070
Enrollment
100
Registered
2009-04-06
Start date
2009-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke, post-stroke shoulder pain CVA, hemiplegische schouderpijn

Interventions

None listed

Sponsors

University of Twente
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Older than 18 years; 2. Legally competent; 3. Able to communicate; 4. First-ever unilateral CVA (ischemic or hemorrhagic) of the middle cerebral artery (if possible confirmation by CT or MRI scan); 5. Somatosensory and motor loss during baseline measurement (0-2 weeks after stroke); 6. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. HIV/AIDS; 3. Any other brain disease (trauma, tumor, parkinson, multiple sclerosis); 4. Any peripheral neurological disease (amputation, neuropathy); 5. Pre-existent psychiatric disorders; 6. Pre-existent use of psychotropic substances or medication; 7. Chronic pain complaint (> 3 subsequent months) in the 6 months prior to stroke.

Design outcomes

Primary

MeasureTime frame
Baseline assessment consists of a questionnaire that assesses pain complaints (current, past), clinical neurological tests (touch, temperature, sharpness) and tests for motor function. Moreover, general neurologic status and emotional status are assessed. Follow-up measurements consist of the assessment of pain complaints (quality, quantity) and the assessment of somatosensory and nociceptive changes using quantitative sensory testing and cold pressor testing.

Secondary

MeasureTime frame
1. Motor function; 2. Depression.

Contacts

Public ContactM. Roosink

P.O. box 217

m.roosink@utwente.nl+31 (0)53 4892740

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)